Eli Lilly and Company

Patent Owner

Follow Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 516 20
 
 
C07D HETEROCYCLIC COMPOUNDS 319 14
 
 
C07K PEPTIDES 100 35
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 63 30
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 49 78
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 45 105
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 43 39
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 40 85
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 34 68
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 60
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0335,096 ANTI-GLUCAGON ANTIBODIES AND USES THEREOF Nov 27, 12 Nov 13, 14 [G01N, C07K]
2014/0309,251 SPIROTHIENOPYRAN-PIPERIDINE DERIVATIVES AS ORL-1 RECEPTOR ANTAGONISTS FOR THEIR USE IN THE TREATMENT OF ALCOHOL DEPENDENCE AND ABUSE Nov 29, 12 Oct 16, 14 [C07D]
2014/0296,782 INJECTION DEVICES WITH ERGONOMIC ENHANCEMENTS Nov 07, 12 Oct 02, 14 [A61M]
2014/0271,647 Pan-ELR+ CXC CHEMOKINE ANTIBODIES Mar 11, 14 Sep 18, 14 [C07K]
2014/0271,671 RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR Mar 14, 13 Sep 18, 14 [C12Q]
2014/0271,675 THERAPEUTIC USES FOR VEGFR1 ANTIBODIES Mar 11, 14 Sep 18, 14 [C07K]
2014/0275,002 AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS Mar 07, 14 Sep 18, 14 [C07D, A61K]
2014/0275,044 TETRAHYDROPYRROLOTHIAZINE COMPOUNDS Mar 04, 14 Sep 18, 14 [C07D]
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0275,121 CDC7 Inhibitors Mar 07, 14 Sep 18, 14 [C07D]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,883,726 Fibroblast growth factor 21 variants Aug 13, 13 Nov 11, 14 [A61K, C07K]
8,871,727 Ectoparasiticidal methods and formulations Jun 16, 10 Oct 28, 14 [A01N, A61K]
8,864,721 Gearing mechanism for a dose delivery device Sep 23, 11 Oct 21, 14 [A61M]
8,862,481 Method and system for collecting, managing and reporting feedlot data and feed additive consumption data Jun 29, 07 Oct 14, 14 [A01K, G06Q, A23K]
8,841,293 Tetrahydropyrrolothiazine compounds Mar 04, 14 Sep 23, 14 [C07D, A61K]
8,822,486 Spiropiperidine compounds Nov 19, 10 Sep 02, 14 [C07D]
8,815,811 Peptides and methods for their preparation and use Mar 23, 11 Aug 26, 14 [A61P, A61K, C07K]
8,802,668 Hematopoietic neoplasm chemotherapy Apr 08, 10 Aug 12, 14 [A61K]
8,802,728 Analgesic compounds, methods, and formulations Jan 13, 12 Aug 12, 14 [A01N, C07C, A61K]
8,795,665 BMP-6 antibodies Dec 05, 13 Aug 05, 14 [A61K, C07K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA Oct 28, 10 Nov 22, 12 [A61P, A61K]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT May 27, 10 Sep 13, 12 [A61P, A61K]
2012/0172,422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid Mar 13, 12 Jul 05, 12 [A61P, A61K]
2012/0022,140 Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel Sep 28, 11 Jan 26, 12 [A61P, A61K]
2011/0294,792 PURINE DERIVATIVES AS KINASE INHIBITORS Aug 09, 11 Dec 01, 11 [C07D, A61P, A61K]
2011/0287,019 THERAPEUTIC TARGETING OF ESCORT PROTEINS Jun 13, 11 Nov 24, 11 [A61P, A61K, C07K]
2011/0288,032 ENZASTAURIN FOR THE TREATMENT OF CANCER Dec 07, 09 Nov 24, 11 [A61P, A61K]
2011/0212,092 GLUCAGON RECEPTOR ANTAGONISTS May 16, 11 Sep 01, 11 [A61P, A61K, C07K]
2011/0212,977 P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY Nov 04, 09 Sep 01, 11 [A61P, A61K]
2011/0207,670 COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS Oct 21, 09 Aug 25, 11 [A61P, A61K, C07K]
2011/0177,195 ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS Mar 25, 11 Jul 21, 11 [A23K]
2011/0105,392 Pegylated Insulin Lispro Compounds Jun 09, 09 May 05, 11 [A61P, A61K, C07K]
2011/0034,373 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY Jul 30, 08 Feb 10, 11 [A61P, A61K]
2011/0034,511 SUBSTITUTED 2-CARBONYLAMINO-6-PIPERIDINAMINOPYRIDINES AND SUBSTITUTED 1-CARBONYLAMINO-3-PIPERIDINAMINOBENZENES AS 5-HT1F AGONISTS Sep 28, 10 Feb 10, 11 [C07D, A61P, A61K]
2010/0324,140 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Aug 26, 10 Dec 23, 10 [A61P, C07C, A61K]
2010/0286,139 AMINO PYRAZOLE COMPOUND Dec 08, 09 Nov 11, 10 [C07D, A61P, A61K]
7,816,349 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 Apr 23, 07 Oct 19, 10 [C07D, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL